Quantitative differentiation of whole smoke solution‐induced mutagenicity in the mouse lymphoma assay |
| |
| Authors: | Xiaoqing Guo Robert H. Heflich Stacey L. Dial Mamata De Patricia A. Richter Nan Mei |
| |
| Affiliation: | 1. Division of Genetic and Molecular Toxicology, National Center for Toxicological Research, Jefferson, Arkansas;2. Center for Tobacco Products, Silver Spring, Maryland |
| |
| Abstract: | In vitro genotoxicity dose–response data have been investigated for their utility in modeling and assessing potential differences in mutagenic responses between machine‐generated whole smoke solutions (WSSs) from combusted cigarette tobacco products. Our previous study observed that potency ranking by benchmark dose (BMD) analysis was a useful modeling approach for quantitative assessment of differences between the mutagenicity of several structurally diverse chemical constituents of cigarette smoke. To follow‐up on these observations, we used the mouse lymphoma assay (MLA) to evaluate the mutagenicity of WSSs prepared from two commercial cigarettes smoked under two different smoking machine regimens. L5178Y cells were exposed to ≥5 concentrations of each WSS for 4 hr ± S9 activation. S9 reduced the cytotoxicity and enhanced the mutagenicity of the WSSs. The resulting S9‐mediated mutagenicity dose–responses were compared between test articles using BMD analysis, the lowest dose exceeding the Global Evaluation Factor, the no observed or lowest observed genotoxic effect level, and the mutagenic potency. The BMD10, BMD50, BMD100, and BMD200, indicating a 10%, 50%, 100%, or 200% increase in the background mutant frequency, respectively, were calculated using the PROAST software package. Overall, the quantitative approaches resulted in a similar rank order of mutagenic potency for the MLA tested WSSs, with potency increasing with the level of tar. The BMD approach using covariate analysis produced the most informative comparisons. Differences in potency were associated with the number of cigarettes smoked, the cigarette product smoked, and the smoking machine protocol used to prepare the sample. Under the conditions of this study, these results suggest that our hypothesis of modeling MLA data using the BMD approach to quantitatively discriminate between the mutagenic potential of WSSs from combustible cigarettes might be an useful method. Environ. Mol. Mutagen. 59:103–113, 2018. Published 2017. This article is a US Government work and is in the public domain in the USA. |
| |
| Keywords: | whole smoke solution mouse lymphoma assay quantitative analysis benchmark dose |
|
|
